SCHEMBL1993702

SCHEMBL1993702

CN(C)CCCCn1cc(C2=C(c3c[nH]c4sccc34)C(=O)NC2=O)c2ccccc21

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 8/20 0.70
PRKCB P05771 7/20 0.70
PRKCE Q02156 6/20 0.70
PRKACA P17612 6/20 0.70
PRKACG P22612 6/20 0.70
PRKACB P22694 6/20 0.70
PRKCH P24723 3/20 0.70
PRKCQ Q04759 3/20 0.70
PRKCD Q05655 3/20 0.70
CCNB2 O95067 3/20 0.70
CDK1 P06493 3/20 0.70
CCNB1 P14635 3/20 0.70
CCNB3 Q8WWL7 3/20 0.70
CDK4 P11802 3/20 0.70
CCND1 P24385 3/20 0.70
PIM1 P11309 2/20 0.70
PRKD1 Q15139 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
MEN1 O00255 1/20 0.70
PRKD3 O94806 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994400 0.93 PRKACA (0.65) PRKCAPRKCBPRKCEPRKACAPRKACG
SCHEMBL1991783 0.86 PRKACA (0.72) PRKCAPRKCBPRKCEPRKACAPRKACG
SCHEMBL1992099 0.83 PRKCA (0.62) PRKCAPRKCBPRKCEPRKACAPRKACG
Gf-109203 SCHEMBL338086 0.82 PRKACA (1.00) PRKCAPRKCBPRKCEPRKACAPRKACG
Gf-109203 SCHEMBL29353725 0.82 PRKACA (1.00) PRKCAPRKCBPRKCEPRKACAPRKACG
Gf-109203 SCHEMBL1199513 0.82 PRKACA (0.98) PRKCAPRKCBPRKCEPRKACAPRKACG
Gf-109203 SCHEMBL29534077 0.82 PRKACA (0.98) PRKCAPRKCBPRKCEPRKACAPRKACG
SCHEMBL1991771 0.80 PRKCA (0.65) PRKCAPRKCBPRKCEPRKACAPRKACG
SCHEMBL1990249 0.79 PRKACA (0.67) PRKCAPRKCBPRKCEPRKACAPRKACG
SCHEMBL7057981 0.79 PRKCA (1.00) PRKCAPRKCBPRKCEPRKACAPRKACG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCA 3438/4885PRKCB 3335/4885PRKCE 3431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.